CIK: 0002026172
Total reported value
$587.7M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 5.84% | -1.32% | +12.08% | |
| 2 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 5.66% | -0.64% | EXIT | |
| 3 | QURE | uniQure N.V. | Stock-Other | 4.48% | — | +188.18% | |
| 4 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 4.34% | -2.03% | EXIT | |
| 5 | VKTX | Viking Therapeutics INC | Stock-Healthcare | 4.02% | -1.58% | +203.23% | |
| 6 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 3.58% | — | — | |
| 7 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 3.41% | — | — | |
| 8 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 2.95% | — | +10.37% | |
| 9 | RNAGBP | Avidity Biosciences INC | Stock-Other | 2.56% | -4.08% | EXIT | |
| 10 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 2.28% | — | +81.90% | |
| 11 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.17% | — | -28.35% | |
| 12 | INCY | Incyte CORP | Stock-Healthcare | 2.17% | +1.24% | — | |
| 13 | NTLA | Intellia Therapeutics INC | Stock-Other | 2.08% | — | — | |
| 14 | PCVX | Vaxcyte INC | Stock-Other | 2.01% | +0.59% | +10.09% | |
| 15 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.95% | +0.57% | -78.03% | |
| 16 | APGE | Apogee Therapeutics INC | Stock-Other | 1.95% | +0.45% | +14.85% | |
| 17 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 1.86% | — | — | |
| 18 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 1.77% | — | +25.00% | |
| 19 | HRMY | Harmony Biosciences Holdings | Stock-Other | 1.76% | — | — | |
| 20 | BBIO | Bridgebio Pharma INC | Stock-Healthcare | 1.75% | -4.32% | — | |
| 21 | MNKD | Mannkind CORP | Stock-Other | 1.72% | -0.75% | +140.81% | |
| 22 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 1.67% | -1.45% | EXIT | |
| 23 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 1.63% | — | — | |
| 24 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 1.57% | -1.47% | EXIT | |
| 25 | MRNA | Moderna INC | Stock-Healthcare | 1.47% | +1.38% | NEW | |
| 26 | ASND | Ascendis Pharma A/S | Stock-Other | 1.40% | — | — | |
| 27 | PRAX | Praxis Precision Medicines I | Stock-Other | 1.36% | -5.11% | EXIT | |
| 28 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 1.36% | — | -59.85% | |
| 29 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.17% | — | — | |
| 30 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 1.16% | +0.57% | +19.16% | |
| 31 | COGT | Cogent Biosciences INC | Stock-Other | 1.09% | +1.30% | -50.41% | |
| 32 | NKTR | Nektar Therapeutics | Stock-Other | 1.09% | — | +57.98% | |
| 33 | 430 | Terns Pharmaceuticals INC | Stock-Other | 1.05% | -1.23% | +30.33% | |
| 34 | UPB | Upstream Bio INC | Stock-Other | 0.96% | — | — | |
| 35 | SRRK | Scholar Rock Holding CORP | Stock-Other | 0.95% | — | +58.92% | |
| 36 | ARCT | Arcturus Therapeutics Holdin | Stock-Other | 0.94% | — | — | |
| 37 | ABVX | Abivax Sa-adr | Stock-Other | 0.90% | +3.43% | — | |
| 38 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 0.87% | -0.52% | EXIT | |
| 39 | PTGX | Protagonist Therapeutics INC | Stock-Other | 0.87% | — | -32.81% | |
| 40 | ZYME | Zymeworks INC | Stock-Other | 0.86% | -0.58% | +9.59% | |
| 41 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.82% | — | +14.93% | |
| 42 | ANIP | Ani Pharmaceuticals INC | Stock-Other | 0.74% | -0.73% | EXIT | |
| 43 | RVMD | Revolution Medicines INC | Stock-Healthcare | 0.71% | +2.90% | -78.83% | |
| 44 | SCPH | Scpharmaceuticals INC | Stock-Other | 0.67% | — | -34.39% | |
| 45 | REPL | Replimune Group INC | Stock-Other | 0.66% | +0.61% | +1784.99% | |
| 46 | ABUS | Arbutus Biopharma CORP | Stock-Other | 0.60% | -0.45% | EXIT | |
| 47 | ARDX | Ardelyx INC | Stock-Other | 0.56% | — | — | |
| 48 | CORT | Corcept Therapeutics INC | Stock-Healthcare | 0.56% | — | -73.55% | |
| 49 | TGTX | Tg Therapeutics INC | Stock-Healthcare | 0.56% | — | -83.65% | |
| 50 | GOSS | Gossamer Bio INC | Stock-Other | 0.55% | -0.47% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | QURE | uniQure N.V. | +4% | +188.18% | Add |
| 2 | VKTX | Viking Therapeutics INC | +3.1% | +203.23% | Add |
| 3 | BMRN | Biomarin Pharmaceutical INC | +2% | +10.37% | Add |
| 4 | AGIO | Agios Pharmaceuticals INC | +1.4% | +81.90% | Add |
| 5 | ASND | Ascendis Pharma A/S | +1.1% | — | Add |
| 6 | MNKD | Mannkind CORP | +1% | +140.81% | Add |
| 7 | 430 | Terns Pharmaceuticals INC | +1% | +30.33% | Add |
| 8 | CRSP | CRISPR Therapeutics AG | +0.9% | — | Unchanged |
| 9 | JAZZ | Jazz Pharmaceuticals plc | +0.7% | +12.08% | Add |
| 10 | PCVX | Vaxcyte INC | +0.6% | +10.09% | Add |
| 11 | BBIO | Bridgebio Pharma INC | +0.6% | — | Unchanged |
| 12 | ANAB | Anaptysbio INC | -1% | — | Trim |
| 13 | ALNY | Alnylam Pharmaceuticals INC | -1.2% | — | Trim |
| 14 | TGTX | Tg Therapeutics INC | -1.6% | -83.65% | Trim |
| 15 | NVO | Novo-nordisk A/s-spons Adr | -2.9% | +25.00% | Trim |
| 16 | REGN | Regeneron Pharmaceuticals | -3.9% | +437.90% | Trim |
| 17 | SLNOEUR | Soleno Therapeutics INC | -4.2% | +15.20% | Trim |
| 18 | CORT | Corcept Therapeutics INC | -5.1% | -73.55% | Trim |
| 19 | LLY | Eli Lilly & Co | -8.8% | -78.03% | Trim |
| 20 | AMGN | Amgen INC | — | EXIT | Sold out |
| 21 | PFE | Pfizer INC | — | EXIT | Sold out |
| 22 | BMY | Bristol-myers Squibb Co | — | NEW | New buy |
| 23 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | New buy |
| 24 | RNAGBP | Avidity Biosciences INC | — | NEW | New buy |
| 25 | INCY | Incyte CORP | — | NEW | New buy |
| 26 | NTLA | Intellia Therapeutics INC | — | NEW | New buy |
| 27 | ARGX | Argenx Se - Adr | — | EXIT | Sold out |
| 28 | HRMY | Harmony Biosciences Holdings | — | NEW | New buy |
| 29 | IONS | Ionis Pharmaceuticals INC | — | NEW | New buy |
| 30 | ROIV | Roivant Sciences Ltd. | — | NEW | New buy |
| 31 | INDV | Indivior Pharmaceuticals, Inc. | — | NEW | New buy |
| 32 | PRAX | Praxis Precision Medicines I | — | NEW | New buy |
| 33 | NKTR | Nektar Therapeutics | — | NEW | New buy |
| 34 | UPB | Upstream Bio INC | — | NEW | New buy |
| 35 | ARCT | Arcturus Therapeutics Holdin | — | NEW | New buy |
| 36 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 37 | PTGX | Protagonist Therapeutics INC | — | NEW | New buy |
| 38 | ANIP | Ani Pharmaceuticals INC | — | NEW | New buy |
| 39 | RVMD | Revolution Medicines INC | — | NEW | New buy |
| 40 | 4XC1 | Kalvista Pharmaceuticals INC | — | EXIT | Sold out |
| 41 | RYTM | Rhythm Pharmaceuticals INC | — | EXIT | Sold out |
| 42 | SWTXUSD | Springworks Therapeutics INC | — | EXIT | Sold out |
| 43 | SCPH | Scpharmaceuticals INC | — | NEW | New buy |
| 44 | 260 | Centessa Pharmaceuticals-adr | — | EXIT | Sold out |
| 45 | ABUS | Arbutus Biopharma CORP | — | NEW | New buy |
| 46 | ARDX | Ardelyx INC | — | NEW | New buy |
| 47 | VRDN | Viridian Therapeutics INC | — | EXIT | Sold out |
| 48 | KROS | Keros Therapeutics INC | — | EXIT | Sold out |
| 49 | ALKS | Alkermes plc | — | NEW | New buy |
| 50 | EWTX | Edgewise Therapeutics INC | — | EXIT | Sold out |